Cleared Traditional

K953175 - AS/3 ESTPR MODULE

K953175 is an FDA 510(k) clearance for AS/3 ESTPR MODULE, manufactured by Datex Division Instrumentarium Corp.. The device is a Class 2 Cardiovascular device with product code MLD cleared through the Traditional 510(k) pathway after a 580-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 1997
Decision
580d
Days
Class 2
Risk

K953175 is an FDA 510(k) clearance for the AS/3 ESTPR MODULE. Classified as Monitor, St Segment With Alarm (product code MLD), Class II - Special Controls.

Submitted by Datex Division Instrumentarium Corp. (Tewksbury, US). The FDA issued a Cleared decision on February 6, 1997 after a review of 580 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1025 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Cardiovascular submissions.

View all Datex Division Instrumentarium Corp. devices

FDA 510(k) Submission Details - K953175

510(k) Number K953175 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 07, 1995
Decision Date February 06, 1997
Days to Decision 580 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
455d slower than avg
Panel avg: 125d · This submission: 580d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

MLD Device Classification - Class 2, Special Controls

Product Code MLD Monitor, St Segment With Alarm
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1025
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - MLD Monitor, St Segment With Alarm

All 11
Devices cleared under the same product code (MLD) and FDA review panel - the closest regulatory comparables to K953175.
DATEX-OHMEDA CARDIOCAP 5, F-MX, F-MXG AND ACCESSORIES
K992323 · Datex-Ohmeda, Inc. · Nov 1999
ESCORT-LINK CENTRAL STATION MONITOR MODEL 20500
K982104 · Medical Data Electronics · Nov 1998
SIEMENS SC6000/SC6000P BEDSIDE MONITORING SYSTEM ENHANCED WITH ST SEGMENT ANALYSIS
K974492 · Siemens Medical Solutions USA, Inc. · Feb 1998
EAGLE 3000/3100 PATIENT MONITOR
K960272 · Marquette Electronics, Inc. · Oct 1996
HP M1205A OMNICARE COMPONENT MONITOR SYSTEM MODEL 24
K960934 · Hewlett-Packard Co. · Jun 1996
MODIFIED MODEL M1403A TELEMETRY MONITORING SYSTEM
K920429 · Hewlett-Packard Co. · Jul 1993